Carmine Carpenito

Carmine Carpenito

UNVERIFIED PROFILE

Are you Carmine Carpenito?   Register this Author

Register author
Carmine Carpenito

Carmine Carpenito

Publications by authors named "Carmine Carpenito"

Are you Carmine Carpenito?   Register this Author

28Publications

767Reads

18Profile Views

ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells.

Blood 2014 Aug 1;124(7):1070-80. Epub 2014 Jul 1.

Abramson Cancer Center and the Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-10-535245DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133482PMC
August 2014

Treatment of advanced leukemia in mice with mRNA engineered T cells.

Hum Gene Ther 2011 Dec 23;22(12):1575-86. Epub 2011 Sep 23.

Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/hum.2011.070DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237694PMC
December 2011

Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling.

Blood 2011 Oct 19;118(15):e112-7. Epub 2011 Aug 19.

Department of Pediatrics, Division of Oncology, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2011-04-34
Publisher Site
http://dx.doi.org/10.1182/blood-2011-04-346528DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204743PMC
October 2011

A human memory T cell subset with stem cell-like properties.

Nat Med 2011 Sep 18;17(10):1290-7. Epub 2011 Sep 18.

Center for Cancer Research, National Cancer Institute, US National Institutes of Health (NIH), Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.2446DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192229PMC
September 2011

In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB).

Cancer Res 2011 Jul 5;71(13):4617-27. Epub 2011 May 5.

Ovarian Cancer Research Center, Department of Obstetrics and Gynecology and Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-0422DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140173PMC
July 2011

Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor.

Cancer Res 2010 Nov 5;70(22):9053-61. Epub 2010 Oct 5.

Abramson Family Cancer Research Institute and Department of Pathology and Laboratory Medicine and Thoracic Oncology Research Laboratory and Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6160, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-2880DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982929PMC
November 2010

The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells.

Sci Transl Med 2010 Oct;2(55):55ra78

Abramson Family Cancer Research Institute, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3000448DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282816PMC
October 2010

Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo.

Mol Ther 2009 Aug 21;17(8):1453-64. Epub 2009 Apr 21.

Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104-5160, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2009.83DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805264PMC
August 2009

Genetic engineering of T cells for adoptive immunotherapy.

Immunol Res 2008 ;42(1-3):166-81

Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, University of Pennsylvania, 421 Curie Blvd-556 BRB II/III, Philadelphia, PA, 19104, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12026-008-8057-6
Publisher Site
http://dx.doi.org/10.1007/s12026-008-8057-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699549PMC
March 2009

Expression of murine killer immunoglobulin-like receptor KIRL1 on CD1d-independent NK1.1(+) T cells.

Immunogenetics 2007 Aug 22;59(8):641-51. Epub 2007 May 22.

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00251-007-0216-8DOI Listing
August 2007

Identification of sequence motifs responsible for the adhesive interaction between exon v10-containing CD44 isoforms.

J Biol Chem 2002 Dec 28;277(52):50529-34. Epub 2002 Oct 28.

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M206719200DOI Listing
December 2002

Alternative splicing as a novel of means of regulating the expression of therapeutic genes.

Cancer Gene Ther 2002 Feb;9(2):133-41

Department of Radiation Oncology, UCLA Center for Health Sciences, Los Angeles, California 90095-1724, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.cgt.7700427DOI Listing
February 2002